To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C20orf29andMAVSTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
434 representative clones for gene C20orf29andMAVS back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB219666 trachea .a 1 to 548 4 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
NM_020746.3   .a 1 to 11760 1 to 11760 exact RefSeq,   11760/11760
(100 %)
0 diff
(100 %id)
DB068246 testis .a 1 to 541 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA186132 amygdala .a 34 to 597 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA444081 tongue, tumor tissue .a 34 to 622 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA453506 tongue, tumor tissue .a 34 to 601 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA495153 brain .a 34 to 594 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA814514   .a 34 to 590 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BM834250 stomach .a 34 to 512 1 to 479       479/479
(100 %)
0 diff
(100 %id)
DB147015 thymus .a 34 to 612 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA949475 Spleen .a 35 to 586 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA301623 hippocampus .a 36 to 588 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DC402852 testis .a 36 to 405 1 to 370       370/370
(100 %)
0 diff
(100 %id)
DB130670 thymus .a 36 to 594 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA010849 adrenal gland .a 37 to 612 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA032966   .a 37 to 605 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA403208 thalamus .a 37 to 575 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA497080 brain .a 37 to 625 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA787866 brain .a 37 to 542 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA808269 brain .a 37 to 604 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB003942 breast, tumor tissue .a 37 to 578 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB152108 thymus .a 37 to 585 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB205356 trachea .a 37 to 613 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA456109 tongue, tumor tissue .a 38 to 613 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB141387 thymus .a 40 to 552 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DB214345 trachea .a 41 to 598 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB241368 trachea .a 41 to 633 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
AK023799 placenta .a 42 to 3970 1 to 3928 P333L G334V A335Q V336C P337L ... available from FLJ,   3928/3928
(100 %)
5 diff
(99.9 %id)
AX775775   .a 42 to 3970 1 to 3929 exact tiling clone,   3929/3929
(100 %)
1 diff
(100.0 %id)
DB151631 thymus .a 43 to 576 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DN999691   .a 46 to 665 1 to 620       620/620
(100 %)
5 diff
(99.2 %id)
BM476249 duodenal adenocarcinoma, cell line, small intestine .a 48 to 1028 1 to 993       993/1029
(96 %)
28 diff
(97.3 %id)
BI820827 pooled brain, lung, testis .a 49 to 821 1 to 771       771/771
(100 %)
6 diff
(99.3 %id)
BI910105 leukocyte .a 60 to 723 1 to 664       664/664
(100 %)
3 diff
(99.6 %id)
BC044952 Brain, Lung, Testis, adult, pooled whole .a 64 to 2970 1 to 2908 Q93E Q198K S409F available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2908/2908
(100 %)
7 diff
(99.8 %id)
BQ067290 pooled brain, lung, testis .a 65 to 1017 1 to 964       964/1116
(86 %)
30 diff
(97.4 %id)
CR613265 B cells (Ramos cell line) Cot 25-normalized .a 71 to 1798 1 to 1728 exact     1728/1728
(100 %)
0 diff
(100 %id)
BX385472   .a 71 to 1033 1 to 956       956/1025
(93 %)
18 diff
(98.3 %id)
BF530667 anaplastic oligodendroglioma with 1p/19qloss, brain .a 75 to 856 1 to 790       684/982
(69 %)
17 diff
(98.3 %id)
BF796906 lymph, lymphoma, cell line .a 75 to 799 1 to 728       728/760
(95 %)
24 diff
(96.9 %id)
BX421695 T cells (Jurkat cell line) .a 76 to 1086 1 to 1008       1008/1039
(97 %)
17 diff
(98.4 %id)
BM789127 stomach .a 77 to 754 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
DA319840 hippocampus .a 78 to 626 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA765125 tongue .a 78 to 655 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA816610   .a 82 to 653 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB159777 thymus .a 82 to 661 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AB033097 brain .a 92 to 4278 1 to 4187 exact tiling clone, available from KIAA,   4187/4187
(100 %)
29 diff
(99.4 %id)
AB232371   .a 98 to 2970 1 to 2873 exact AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2873/2873
(100 %)
3 diff
(99.9 %id)
AL547611 placenta, Placenta Cot 25-normalized .a 99 to 1218 1 to 1117       1117/1133
(98 %)
34 diff
(97.0 %id)
BX402259 Placenta Cot 25-normalized .a 101 to 1191 1 to 1085       1085/1085
(100 %)
19 diff
(98.3 %id)
CB044346 colon, juvenile granulosa tumor .a 118 to 754 19 to 655     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 637/655
(97 %)
7 diff
(99.0 %id)
DQ167126   .a 170 to 1792 1 to 1623 exact     1623/1623
(100 %)
0 diff
(100 %id)
DQ174270   .a 170 to 1792 1 to 1623 Q93E Q198K S409F     1623/1623
(100 %)
3 diff
(99.9 %id)
DQ181928   .a 170 to 1792 1 to 1623 Q93E Q198K S409F     1623/1623
(100 %)
3 diff
(99.9 %id)
DA404884 thalamus .a 225 to 743 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
BM453893 melanotic melanoma, skin .a 232 to 1117 1 to 890       890/890
(100 %)
8 diff
(99.2 %id)
BX401777   .a 283 to 1328 1 to 1038       1038/1038
(100 %)
10 diff
(99.1 %id)
CN346813 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 309 to 987 1 to 679       679/679
(100 %)
3 diff
(99.6 %id)
BX391042   .a 829 to 1766 1 to 931       931/936
(99 %)
20 diff
(97.9 %id)
BX356271 Placenta Cot 25-normalized .a 855 to 1905 1 to 1038       1038/1068
(97 %)
15 diff
(98.6 %id)
BM806508 leiomyosarcoma, uterus .a 982 to 2016 38 to 1077       1040/1077
(96 %)
38 diff
(96.5 %id)
TI_1948213303   .a 982 to 1796 941 to 123       819/1274
(64 %)
23 diff
(98.2 %id)
BI333679 cervical carcinoma cell line, cervix .a 988 to 1742 1 to 760       760/913
(83 %)
23 diff
(97.5 %id)
BI334883 cervical carcinoma cell line, cervix .a 989 to 1883 1 to 892       892/893
(99 %)
22 diff
(97.6 %id)
BQ230081 embryonal carcinoma, cell line, testis .a 993 to 1741 1 to 753       753/945
(79 %)
16 diff
(98.4 %id)
CN346811 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1073 to 1661 1 to 589       589/589
(100 %)
0 diff
(100 %id)
DA687662   .a 1073 to 1626 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BM467911 leiomyosarcoma, uterus .a 1084 to 2085 1 to 1001       1001/1085
(92 %)
49 diff
(95.5 %id)
DA841134 placenta .a 1132 to 1690 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BG171188 hypernephroma, cell line, Kidney .a 1216 to 1890 1 to 673       673/673
(100 %)
6 diff
(99.2 %id)
BU164340 large cell carcinoma, lung .a 1280 to 2069 1 to 805       805/912
(88 %)
22 diff
(97.6 %id)
BG752845 eye, normal pigmented retinal epithelium .a 1499 to 2353 1 to 860       860/860
(100 %)
15 diff
(98.3 %id)
BG171641 hypernephroma, cell line, Kidney .a 1624 to 2300 1 to 678       678/680
(99 %)
10 diff
(98.6 %id)
TI_154197096   .a 1658 to 2535 62 to 930       869/1015
(85 %)
41 diff
(96.0 %id)
BU185620 ductal carcinoma, cell line, Pancreas .a 1666 to 2418 1 to 760       760/947
(80 %)
11 diff
(98.9 %id)
BU174742 ductal carcinoma, cell line, Pancreas .a 1666 to 2587 1 to 928   tiling clone,   928/972
(95 %)
20 diff
(98.0 %id)
BG818963 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1696 to 2445 1 to 751       751/751
(100 %)
10 diff
(98.7 %id)
BG171674 hypernephroma, cell line, Kidney .a 1708 to 2415 1 to 705       705/766
(92 %)
14 diff
(98.2 %id)
BE292742 adenocarcinoma cell line, colon .a 1756 to 2348 1 to 595       595/595
(100 %)
3 diff
(99.5 %id)
BX401776   .a 1808 to 2934 1107 to 1       1107/1107
(100 %)
27 diff
(97.6 %id)
CN391060 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1890 to 2579 1 to 690       690/690
(100 %)
7 diff
(99.0 %id)
BX504554   .a 1909 to 2537 1 to 629       629/629
(100 %)
0 diff
(100 %id)
DB206618 trachea .a 1933 to 2472 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BX402258 Placenta Cot 25-normalized .a 1946 to 2936 982 to 1       982/1045
(93 %)
11 diff
(99.0 %id)
CF457149 peripheral nervous system .a 1968 to 2717 31 to 778       748/780
(95 %)
3 diff
(99.7 %id)
EC556970 Prostate .a 1973 to 2080 109 to 2       108/110
(98 %)
0 diff
(100 %id)
EC440842 Prostate .a 1978 to 2074 106 to 10       97/110
(88 %)
0 diff
(100 %id)
EC545721 Prostate .a 2052 to 2146 100 to 6       95/100
(95 %)
0 diff
(100 %id)
EC531323 Prostate .a 2090 to 2181 102 to 13       90/102
(88 %)
0 diff
(100 %id)
BQ668785 epidermoid carcinoma, cell line, salivary gland .a 2097 to 2975 18 to 898       881/938
(93 %)
15 diff
(98.5 %id)
DB227695 trachea .a 2120 to 2672 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BM561858 blood, natural killer cells, cell line .a 2152 to 2971 872 to 41     Submitted on the opposite strand 832/1062
(78 %)
0 diff
(100 %id)
BG744447 blood, natural killer cells, cell line .a 2186 to 2917 1 to 728       728/729
(99 %)
12 diff
(98.4 %id)
DA624683 Kidney .a 2280 to 2821 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BM917531 blood, natural killer cells, cell line .a 2351 to 2971 661 to 39     Submitted on the opposite strand 623/1223
(50 %)
0 diff
(100 %id)
CA428672 Cell Line, Chondrosarcoma .a 2373 to 2970 616 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 598/598
(100 %)
4 diff
(99.4 %id)
CB044345 colon, juvenile granulosa tumor .a 2401 to 2972 590 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 573/573
(100 %)
1 diff
(99.9 %id)
BF204193 muscle, rhabdomyosarcoma .a 2441 to 3183 1 to 732       732/944
(77 %)
20 diff
(97.9 %id)
BF306861 muscle, rhabdomyosarcoma .a 2441 to 3149 1 to 709       709/709
(100 %)
19 diff
(97.4 %id)
AI653175 pooled germ cell tumors .a 2511 to 2970 460 to 1       460/460
(100 %)
0 diff
(100 %id)
CN391061 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2596 to 3285 1 to 689       689/689
(100 %)
5 diff
(99.3 %id)
AA581933 germ cell tumor .a 2610 to 3076 467 to 1       467/467
(100 %)
0 diff
(100 %id)
BM479819 embryonal carcinoma, cell line, testis .a 2660 to 3570 1 to 916       916/1062
(86 %)
28 diff
(97.4 %id)
BQ644558 hepatocellular carcinoma, cell line, Liver .a 2891 to 3807 1 to 930       930/930
(100 %)
27 diff
(97.1 %id)
AI241924 brain, tumor, 5 pooled (see description) .a 2911 to 3077 167 to 1       167/167
(100 %)
0 diff
(100 %id)
BQ324120 colon_ins .a 2976 to 3148 173 to 1       173/173
(100 %)
3 diff
(98.3 %id)
BG179921 adenocarcinoma, cell line, Prostate .a 2988 to 3597 1 to 609       609/609
(100 %)
4 diff
(99.4 %id)
BF840268 head_neck .a 3167 to 3324 158 to 1     Submitted on the opposite strand 158/159
(99 %)
5 diff
(96.9 %id)
BQ711858 Spleen .a 3204 to 3942 1 to 749       749/911
(82 %)
17 diff
(98.2 %id)
AL699465 human skeletal muscle .a 3233 to 3796 564 to 1     Submitted on the opposite strand 564/564
(100 %)
1 diff
(99.9 %id)
BI002259 head_normal .a 3236 to 3769 531 to 1       531/531
(100 %)
13 diff
(97.6 %id)
BI090957 cervix .a 3270 to 3900 1 to 631       631/631
(100 %)
8 diff
(98.8 %id)
BG745092 blood, natural killer cells, cell line .a 3337 to 4208 891 to 26   tiling clone,   866/905
(95 %)
0 diff
(100 %id)
BQ269258 Pancreas, Purified pancreatic islet .a 3347 to 3981 7 to 641       635/641
(99 %)
6 diff
(99.1 %id)
EC475081 Prostate .a 3351 to 3450 100 to 1       100/100
(100 %)
1 diff
(99.0 %id)
EC475252 Prostate .a 3351 to 3450 100 to 1       100/100
(100 %)
1 diff
(99.0 %id)
EC562376 Prostate .a 3351 to 3450 100 to 1       100/100
(100 %)
1 diff
(99.0 %id)
CK825705 Pancreas, Purified pancreatic islet .a 3396 to 3969 1 to 574     Submitted on the opposite strand 574/574
(100 %)
0 diff
(100 %id)
EC450697 Prostate .a 3428 to 3548 120 to 1       120/120
(100 %)
1 diff
(99.2 %id)
BF368919 placenta_normal .a 3460 to 3757 307 to 10       298/307
(97 %)
0 diff
(100 %id)
BQ677677 melanotic melanoma, cell line, skin .a 3465 to 4278 1 to 816   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 816/816
(100 %)
15 diff
(98.2 %id)
BQ679531 melanotic melanoma, cell line, skin .a 3466 to 4151 1 to 682       682/812
(83 %)
24 diff
(97.1 %id)
BQ677346 melanotic melanoma, cell line, skin .a 3466 to 4212 1 to 753       753/934
(80 %)
31 diff
(96.7 %id)
BQ683388 melanotic melanoma, cell line, skin .a 3466 to 4278 1 to 812   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 812/812
(100 %)
17 diff
(98.0 %id)
EC451150 Prostate .a 3542 to 3638 97 to 1       97/97
(100 %)
0 diff
(100 %id)
EC582206 Prostate .a 3542 to 3638 97 to 1       97/97
(100 %)
0 diff
(100 %id)
EC465502 Prostate .a 3543 to 3638 96 to 1       96/96
(100 %)
0 diff
(100 %id)
EC479711 Prostate .a 3543 to 3638 92 to 1       92/92
(100 %)
4 diff
(95.7 %id)
EC480286 Prostate .a 3543 to 3638 96 to 1       96/96
(100 %)
0 diff
(100 %id)
EC494571 Prostate .a 3543 to 3632 99 to 10       90/99
(90 %)
0 diff
(100 %id)
EC538303 Prostate .a 3543 to 3638 95 to 1       95/95
(100 %)
1 diff
(99.0 %id)
EC534347 Prostate .a 3567 to 3664 97 to 3       95/97
(97 %)
0 diff
(100 %id)
BU184831 melanotic melanoma, cell line, skin .a 3608 to 4277 1 to 670   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 670/672
(99 %)
14 diff
(98.0 %id)
BG997771 head_neck .a 3646 to 3972 329 to 4       326/329
(99 %)
0 diff
(100 %id)
BG997768 head_neck .a 3744 to 3973 244 to 18       227/244
(93 %)
0 diff
(100 %id)
AK056260   .a 4294 to 6279 1 to 1984   tiling clone, available from FLJ,   1984/1984
(100 %)
36 diff
(98.2 %id)
DA702951   .a 4295 to 4622 2 to 329   capped   328/328
(100 %)
4 diff
(98.8 %id)
BQ374748 testis_normal .a 4333 to 4514 182 to 4   tiling clone,   179/182
(98 %)
0 diff
(100 %id)
BC040930 Testis, embryonal carcinoma .a 5149 to 6279 1 to 1131   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 1131/1131
(100 %)
6 diff
(99.5 %id)
BF027350 melanotic melanoma, skin .a 5455 to 6255 29 to 824   available from MGC,   796/933
(85 %)
22 diff
(97.7 %id)
CB852534 Human Lung Epithelial cells, lung .a 5458 to 6069 14 to 625     Submitted on the opposite strand 612/638
(95 %)
1 diff
(99.9 %id)
CN415224 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 5462 to 6178 1 to 717       717/717
(100 %)
5 diff
(99.4 %id)
BC062310 Skin, melanotic melanoma. .a 5462 to 6279 1 to 818   available from MGC, AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 818/818
(100 %)
4 diff
(99.6 %id)
BE276239 melanotic melanoma, skin .a 5481 to 6148 1 to 665       665/665
(100 %)
8 diff
(98.8 %id)
BF027061 melanotic melanoma, skin .a 5482 to 6300 1 to 815   tiling clone,   815/833
(97 %)
24 diff
(97.2 %id)
BM709876 eye, optic nerve .a 5586 to 5911 1 to 326   fully sequenced,   326/326
(100 %)
0 diff
(100 %id)
AA148948 uterus .a 5661 to 5986 1 to 328   fully sequenced,   328/328
(100 %)
4 diff
(98.8 %id)
AI817822 normal prostate, Prostate .a 5678 to 6279 602 to 1       602/602
(100 %)
5 diff
(99.2 %id)
DB323797   .a 5745 to 6279 535 to 1       535/535
(100 %)
3 diff
(99.5 %id)
BU734241 eye, optic nerve .a 5881 to 6297 416 to 1   tiling clone, fully sequenced,   416/416
(100 %)
2 diff
(99.6 %id)
AA148949 uterus .a 5956 to 6279 324 to 1   fully sequenced,   324/324
(100 %)
3 diff
(99.1 %id)
DB134326 thymus .a 6386 to 6829 2 to 445   tiling clone, capped   444/444
(100 %)
4 diff
(99.1 %id)
BQ723508 sympathetic trunk .a 6738 to 7522 1 to 795   tiling clone,   795/952
(83 %)
26 diff
(97.3 %id)
BF026769 melanotic melanoma, skin .a 6773 to 7535 1 to 759       759/759
(100 %)
7 diff
(99.1 %id)
DR423793 eye, Pterygium .a 6887 to 7681 1 to 794       794/794
(100 %)
2 diff
(99.8 %id)
AK095370 tongue, tumor tissue .a 6917 to 10042 1 to 3126   available from FLJ,   3126/3126
(100 %)
12 diff
(99.7 %id)
DA444260 tongue, tumor tissue .a 6918 to 7509 2 to 593   capped   592/592
(100 %)
2 diff
(99.7 %id)
BE548839 cervical carcinoma cell line, cervix .a 6953 to 7628 1 to 674       674/674
(100 %)
6 diff
(99.2 %id)
DA477403   .a 6994 to 7562 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BF327256 breast_normal .a 7054 to 7383 330 to 1       330/330
(100 %)
0 diff
(100 %id)
BI007397 kidney_tumor .a 7115 to 7365 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BM454288 lymph, lymphoma, cell line .a 7139 to 7947 13 to 821   tiling clone,   809/1055
(76 %)
9 diff
(99.2 %id)
BP421832 small intestine .a 7215 to 7717 1 to 503     Submitted on the opposite strand 503/503
(100 %)
0 diff
(100 %id)
DA921728 small intestine .a 7217 to 7793 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB242285 stomach, tumor tissue .a 7611 to 8198 2 to 589   capped   588/588
(100 %)
4 diff
(99.4 %id)
BU539066 adenocarcinoma, cell line, breast .a 7764 to 8656 1 to 905   tiling clone,   905/992
(91 %)
25 diff
(97.5 %id)
BC052583 Liver, hepatocellular carcinoma .a 7949 to 9432 1 to 1484   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 1484/1484
(100 %)
0 diff
(100 %id)
BQ643957 hepatocellular carcinoma, cell line, Liver .a 7950 to 8874 1 to 942   available from MGC,   942/942
(100 %)
19 diff
(98.0 %id)
BE744420 adenocarcinoma cell line, ovary .a 7965 to 8744 1 to 787       787/998
(78 %)
35 diff
(96.5 %id)
BQ718198 sympathetic trunk .a 8043 to 8913 1 to 893       893/928
(96 %)
34 diff
(96.4 %id)
DB293087   .a 8103 to 8962 2 to 863   capped   862/867
(99 %)
9 diff
(99.0 %id)
CX752342 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 8117 to 8798 1 to 674     Submitted on the opposite strand 674/794
(84 %)
23 diff
(97.2 %id)
BU539213 adenocarcinoma, cell line, breast .a 8213 to 9078 23 to 896       874/990
(88 %)
18 diff
(98.2 %id)
BU956892 adenocarcinoma, cell line, breast .a 8214 to 9010 1 to 804       804/902
(89 %)
14 diff
(98.5 %id)
BC000073 Kidney, renal cell adenocarcinoma .a 8274 to 10160 1 to 1887   available from MGC, AAA   1887/1895
(99 %)
3 diff
(99.9 %id)
FN120464 breast carcinoma .a 8326 to 8429 105 to 1     Submitted on the opposite strand 105/105
(100 %)
1 diff
(99.1 %id)
EB388153 eye, optic nerve .a 8375 to 9072 1 to 698       698/698
(100 %)
0 diff
(100 %id)
AL390136 brain .a 8409 to 10038 1 to 1630   available from DKFZ, AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 1630/1630
(100 %)
2 diff
(99.9 %id)
BQ899033 eye, normal pigmented retinal epithelium .a 8410 to 9247 1 to 850       850/955
(89 %)
38 diff
(96.1 %id)
BQ956832 epidermoid carcinoma, cell line, lung .a 8431 to 9271 1 to 850       850/976
(87 %)
14 diff
(98.6 %id)
AK092705   .a 8466 to 10045 1 to 1580   available from FLJ,   1580/1580
(100 %)
3 diff
(99.9 %id)
DA900750   .a 8467 to 9205 2 to 739   capped   738/740
(99 %)
9 diff
(98.8 %id)
DR760863 embryonic stem .a 8514 to 9207 1 to 694       694/694
(100 %)
0 diff
(100 %id)
BQ360728 ovary .a 8611 to 8831 233 to 13       221/248
(89 %)
0 diff
(100 %id)
DR157175 human embryonic stem cells differentiated toan early endodermal cell type .a 8665 to 9251 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
BI020263 marrow .a 8759 to 9028 1 to 270       270/270
(100 %)
0 diff
(100 %id)
DA728160   .a 8805 to 9574 2 to 771   capped   770/774
(99 %)
11 diff
(98.6 %id)
BM562790 astrocytoma grade IV, cell line, brain .a 8928 to 9937 1 to 1018       1018/1032
(98 %)
14 diff
(98.7 %id)
BC040719 Lung, large cell carcinoma .a 9160 to 10038 1 to 879   available from MGC, AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 879/879
(100 %)
1 diff
(99.9 %id)
BQ433898 large cell carcinoma, lung .a 9161 to 10043 1 to 891   available from MGC,   891/930
(95 %)
29 diff
(96.9 %id)
AL135056 melanoma (MeWo cell line) .a 9164 to 9809 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
BG332560 large cell carcinoma, lung .a 9204 to 9898 1 to 700       700/846
(82 %)
9 diff
(99.0 %id)
BC063593 Testis, embryonal carcinoma .a 9205 to 11059 1 to 1855   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1855/1855
(100 %)
2 diff
(99.9 %id)
BG390580 embryonal carcinoma, cell line, testis .a 9205 to 10006 1 to 797   available from MGC,   797/817
(97 %)
16 diff
(98.1 %id)
BE884938 leiomyosarcoma, uterus .a 9225 to 10001 1 to 784       784/786
(99 %)
35 diff
(95.6 %id)
BQ774259 Chondrosarcoma Grade II, Left Pelvis .a 9225 to 9880 674 to 19   AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 656/656
(100 %)
2 diff
(99.7 %id)
TI_57165130   .a 9238 to 10001 39 to 811   AAA   773/961
(80 %)
6 diff
(99.4 %id)
BI838629 pooled pancreas and spleen .a 9240 to 10001 1 to 771       771/933
(82 %)
22 diff
(97.7 %id)
T07608   .a 9344 to 9712 1 to 369       369/369
(100 %)
0 diff
(100 %id)
BQ185103 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 9419 to 10038 652 to 26   AAA   627/651
(96 %)
0 diff
(100 %id)
BC028962 Placenta, choriocarcinoma .a 9428 to 11091 1 to 1671   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1671/1671
(100 %)
5 diff
(99.8 %id)
TI_149299352   .a 9438 to 10048 691 to 82   AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 610/767
(79 %)
6 diff
(99.3 %id)
AI082332 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 9461 to 9852 392 to 1       392/392
(100 %)
0 diff
(100 %id)
BQ050901 leiomyosarcoma, uterus .a 9465 to 10249 1 to 793       793/1032
(76 %)
11 diff
(99.0 %id)
DB313887 tongue, tumor tissue .a 9505 to 10042 539 to 1       539/539
(100 %)
2 diff
(99.7 %id)
DB384942   .a 9510 to 10045 537 to 1       537/537
(100 %)
1 diff
(99.9 %id)
AI743334 pooled .a 9516 to 10045 530 to 1       530/530
(100 %)
0 diff
(100 %id)
AI884661 anaplastic oligodendroglioma, brain .a 9523 to 10046 524 to 1       524/524
(100 %)
0 diff
(100 %id)
BM717998 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 9538 to 9786 1 to 249   fully sequenced, Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 249/249
(100 %)
0 diff
(100 %id)
BM680455 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 9756 to 10045 305 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 290/290
(100 %)
1 diff
(99.7 %id)
BU188769 adenocarcinoma, Pancreas .b 1 to 754 1 to 759   tiling clone,   759/919
(82 %)
17 diff
(98.2 %id)
TI_1948213022   .b 81 to 816 118 to 861       744/1386
(53 %)
35 diff
(97.5 %id)
TI_1948213023   .b 81 to 945 119 to 990   tiling clone,   872/1288
(67 %)
23 diff
(98.3 %id)
TI_1948213300   .b 81 to 792 121 to 841       719/1466
(49 %)
32 diff
(97.9 %id)
TI_1948213301   .b 81 to 834 122 to 886       765/1336
(57 %)
25 diff
(98.2 %id)
TI_1948213590   .b 81 to 921 115 to 965       851/1286
(66 %)
36 diff
(97.3 %id)
EL734459 mixed .b 88 to 766 1 to 674       674/679
(99 %)
12 diff
(98.3 %id)
AL833736 stomach .b 756 to 3781 1 to 3027   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 3027/3027
(100 %)
2 diff
(100.0 %id)
CD722484 eye, lacrimal gland .b 1583 to 2201 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
DA385039 thalamus .b 1739 to 2317 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
DA253104 caudate nucleus .c 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
BX649084 Liver .c 4 to 4070 1 to 4066 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 4066/4066
(100 %)
35 diff
(99.2 %id)
DA454540 tongue, tumor tissue .c 4 to 587 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DB140198 thymus .c 4 to 539 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
AK291785 placenta .c 6 to 1712 1 to 1707 T50N tiling clone,   1707/1707
(100 %)
2 diff
(99.9 %id)
DA863840 placenta .c 7 to 580 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
EF467323   .c 137 to 1584 1 to 1448 exact     1448/1448
(100 %)
0 diff
(100 %id)
DA384852 thalamus .c 161 to 718 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AK296897 tongue, tumor tissue .d 1 to 1173 2 to 1174   tiling clone,   1174/1174
(100 %)
2 diff
(99.9 %id)
DC347239 tongue, tumor tissue .d 1 to 537 2 to 538       538/538
(100 %)
0 diff
(100 %id)
DC375415 brain .d 3 to 584 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DC390311 Spleen .d 3 to 568 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC407571 thymus .d 3 to 566 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
BM452871 lymph, lymphoma, cell line .d 19 to 549 1 to 532       532/973
(54 %)
28 diff
(97.2 %id)
EF467324   .d 137 to 1586 1 to 1450 exact tiling clone,   1450/1450
(100 %)
0 diff
(100 %id)
DA959639 Spleen .e 1 to 529 2 to 530   tiling clone, capped   529/529
(100 %)
0 diff
(100 %id)
BP296683   .e 237 to 744 1 to 508       508/585
(86 %)
20 diff
(96.6 %id)
DA129391 alzheimer cortex .e 248 to 811 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DA763550 tongue .e 248 to 811 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA900367 skeletal muscle .e 248 to 713 2 to 468   capped   467/467
(100 %)
1 diff
(99.8 %id)
Z44061 brain, total brain .e 295 to 615 1 to 320       320/320
(100 %)
3 diff
(99.1 %id)
F03263 brain, total brain .e 1596 to 1798 203 to 1   tiling clone,   203/203
(100 %)
4 diff
(98.1 %id)
DB190907 lung, tumor tissue .f 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
DB243408 stomach, tumor tissue .f 1 to 564 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BG675622 skin, squamous cell carcinoma .f 10 to 813 1 to 820 P40R H41M G42V A43P E44R ...     820/820
(100 %)
38 diff
(95.4 %id)
CR610495 fetal brain .f 17 to 1384 1 to 1368 exact tiling clone,   1368/1368
(100 %)
0 diff
(100 %id)
AL539833 brain, fetal brain .f 22 to 1077 4 to 1055 exact     1052/1055
(99 %)
22 diff
(98.0 %id)
CD051129 embryonic trophoblasts, made from WA01 stemcells .f 29 to 846 14 to 834 exact     821/839
(97 %)
11 diff
(98.7 %id)
TI_57217030   .f 29 to 660 26 to 658       633/658
(96 %)
11 diff
(98.4 %id)
BP206504 coronary artery .f 31 to 612 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AK093332 testis .f 32 to 1807 1 to 1776 exact tiling clone, available from FLJ,   1776/1776
(100 %)
2 diff
(99.9 %id)
BP209911 cerebellum .f 32 to 617 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BP212180 cerebrum .f 32 to 612 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DT219408 brain .f 32 to 741 1 to 709       709/712
(99 %)
2 diff
(99.8 %id)
BP262935 small intestine .f 32 to 613 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP367080 thymus .f 32 to 616 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BI755811 brain .f 33 to 660 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
DA896437 skeletal muscle .f 33 to 574 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB031840 testis .f 33 to 599 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB059911 testis .f 33 to 571 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BM014373 breast, mammary adenocarcinoma, cell line .f 187 to 791 149 to 763       615/764
(80 %)
14 diff
(98.2 %id)
TI_59392379   .f 187 to 791 238 to 852       615/764
(80 %)
14 diff
(98.2 %id)
CN426955 embryonic stem cells, DMSO-treated H9 cellline .f 210 to 945 8 to 743       736/743
(99 %)
6 diff
(99.2 %id)
BM796960 Ascites, stomach .f 210 to 609 1 to 400       400/400
(100 %)
2 diff
(99.5 %id)
BG740726 skin .f 231 to 1124 1 to 976       703/976
(72 %)
85 diff
(91.3 %id)
BP265844 thyroid .f 259 to 838 1 to 580       580/580
(100 %)
0 diff
(100 %id)
EC566135 Prostate .f 675 to 772 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
EC461907 Prostate .f 676 to 772 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
CD369294 Alveolar Macrophage, lung .f 767 to 1431 682 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 664/664
(100 %)
4 diff
(99.4 %id)
EL949282 eyeball .f 824 to 1439 1 to 616       616/616
(100 %)
4 diff
(99.4 %id)
BF840641 head_neck .f 884 to 1400 518 to 1     Submitted on the opposite strand 518/518
(100 %)
1 diff
(99.9 %id)
BQ477481 insulinoma, Pancreas .f 887 to 1446 560 to 1       560/560
(100 %)
1 diff
(99.9 %id)
AI186801 lung .f 905 to 1431 527 to 1       527/527
(100 %)
5 diff
(99.1 %id)
BE906844 epithelioid carcinoma, Pancreas .f 914 to 1446 540 to 7     Submitted on the opposite strand 534/540
(98 %)
0 diff
(100 %id)
AW975664   .f 958 to 1400 111 to 553       443/553
(80 %)
6 diff
(99.0 %id)
AA730688 Ewing's sarcoma .f 958 to 1256 7 to 303       297/303
(98 %)
6 diff
(98.1 %id)
BM819947 stomach .f 979 to 1192 1 to 214       214/214
(100 %)
0 diff
(100 %id)
AW190918 adenocarcinoma, Pancreas .f 994 to 1432 441 to 1       441/444
(99 %)
19 diff
(95.8 %id)
AI141176 lung .f 997 to 1430 434 to 1       434/434
(100 %)
3 diff
(99.4 %id)
AW513211 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1027 to 1436 411 to 1       411/411
(100 %)
1 diff
(99.8 %id)
C05900   .f 1051 to 1440 391 to 1       391/391
(100 %)
8 diff
(98.0 %id)
AI338486   .f 1087 to 1440 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AI141087 lung .f 1161 to 1430 270 to 1       270/270
(100 %)
10 diff
(96.3 %id)
DB337089 testis .f 1254 to 1807 554 to 1       554/554
(100 %)
1 diff
(99.9 %id)
AI275071 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1358 to 1802 458 to 7       452/458
(98 %)
0 diff
(100 %id)
BX104804 carcinoid, lung .f 1381 to 1795 425 to 11   AAA Submitted on the opposite strand 415/440
(94 %)
0 diff
(100 %id)
AA988601 carcinoid, lung .f 1382 to 1773 1 to 394     Submitted on the opposite strand 394/394
(100 %)
2 diff
(99.5 %id)
BE045713 carcinoid, lung .f 1382 to 1773 1 to 393     Submitted on the opposite strand 393/393
(100 %)
2 diff
(99.5 %id)
BE042933 carcinoid, lung .f 1382 to 1773 1 to 393     Submitted on the opposite strand 393/393
(100 %)
2 diff
(99.5 %id)
AW087176 lung, cell line .f 1483 to 1801 339 to 20   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 320/320
(100 %)
2 diff
(99.4 %id)
FN066137 breast carcinoma .f 1515 to 1610 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
FN069409 breast carcinoma .f 1515 to 1581 1 to 66       66/68
(97 %)
3 diff
(95.6 %id)
FN060180 breast carcinoma .f 1612 to 1701 1 to 90       90/90
(100 %)
1 diff
(98.9 %id)
BF940609 fibrotheoma, ovary .g 1 to 366 1 to 366   tiling clone, Submitted on the opposite strand 366/366
(100 %)
2 diff
(99.5 %id)
AW296368   .g 2 to 483 1 to 482   tiling clone, Submitted on the opposite strand 482/482
(100 %)
0 diff
(100 %id)
BP303217   .g 260 to 839 1 to 579       579/582
(99 %)
2 diff
(99.7 %id)
DA253969 caudate nucleus .g 261 to 803 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA358446 subthalamic nucleus .g 261 to 812 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB036785 testis .g 261 to 834 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BQ962413 epithelioid carcinoma cell line, Pancreas .g 275 to 1140 1 to 876 E167X L182P N183H L190X E191G ...     876/911
(96 %)
16 diff
(98.3 %id)
BP372446 umbilical cord .g 281 to 860 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP253014 Kidney .g 283 to 862 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BF036366 adenocarcinoma, ovary .g 287 to 1097 1 to 799   available from MGC,   803/1054
(76 %)
9 diff
(99.2 %id)
BP332426 renal proximal tubule .g 290 to 839 1 to 550       550/550
(100 %)
5 diff
(99.1 %id)
BP331148 rectum .g 291 to 872 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP195790 brain .g 292 to 873 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
AK002030 placenta .g 292 to 2123 1 to 1832 exact tiling clone, available from FLJ,   1832/1832
(100 %)
1 diff
(100.0 %id)
CB125501 cervix, Uterine .g 292 to 783 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BP207437 coronary artery .g 292 to 874 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP210266 cerebellum .g 292 to 874 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP252747 Kidney .g 292 to 878 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BP255666 Kidney .g 292 to 873 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA614590   .g 292 to 889 2 to 600   capped   599/599
(100 %)
2 diff
(99.7 %id)
CB134474 Liver .g 292 to 812 1 to 521       521/521
(100 %)
3 diff
(99.5 %id)
NM_018347.1   .g 292 to 2123 1 to 1832 exact RefSeq,   1832/1832
(100 %)
1 diff
(100.0 %id)
BP323867 Pancreas .g 292 to 872 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP351746   .g 292 to 873 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DB026670 testis .g 292 to 846 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BP379851 uterus .g 292 to 872 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
DA081071 cerebellum .g 293 to 850 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA381586 thalamus .g 293 to 906 2 to 615   capped   614/614
(100 %)
0 diff
(100 %id)
BP223153 colon mucosa .g 293 to 1031 1 to 745       745/805
(92 %)
7 diff
(99.2 %id)
DA542179 lung .g 293 to 865 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA562234 heart .g 293 to 860 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA564134 heart .g 293 to 854 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
AU137796 placenta .g 293 to 1033 2 to 741   capped   740/741
(99 %)
9 diff
(98.8 %id)
DA894686 skeletal muscle .g 293 to 845 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA944905 Spleen .g 293 to 845 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB029568 testis .g 293 to 890 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DB203692 trachea .g 293 to 870 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BP255304 Kidney .g 295 to 877 1 to 583       583/585
(99 %)
10 diff
(98.3 %id)
AL528892 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 307 to 1140 1 to 833 L124W V125C L126W D127M A128P ...     833/833
(100 %)
1 diff
(99.9 %id)
BM909281 astrocytoma grade IV, cell line, brain .g 314 to 842 1 to 529       529/1168
(45 %)
12 diff
(99.0 %id)
BG109206 Bone, osteosarcoma, cell line .g 317 to 1026 1 to 706       706/837
(84 %)
5 diff
(99.5 %id)
TI_57216525   .g 317 to 1131 25 to 840 exact     816/840
(97 %)
8 diff
(99.1 %id)
BC043344 Lymph, lymphoma .g 323 to 1747 1 to 1425 exact available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1425/1425
(100 %)
0 diff
(100 %id)
BI755876 brain .g 323 to 1131 1 to 810 exact     810/810
(100 %)
2 diff
(99.8 %id)
BM464914 lymph, lymphoma, cell line .g 324 to 1085 1 to 767       767/1182
(64 %)
8 diff
(99.4 %id)
R15304 whole brain .g 326 to 760 1 to 444       444/467
(95 %)
11 diff
(97.7 %id)
BM829286 Ascites, stomach .g 328 to 877 1 to 551       551/551
(100 %)
2 diff
(99.7 %id)
DA997052   .g 329 to 813 2 to 487   capped   486/486
(100 %)
1 diff
(99.8 %id)
BE907799 epithelioid carcinoma, Pancreas .g 434 to 1008 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
AL528891 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 1209 to 2000 863 to 72       792/800
(99 %)
0 diff
(100 %id)
AU157317 placenta .g 1641 to 2123 481 to 1       481/497
(96 %)
23 diff
(95.4 %id)
BX646970 Liver .h 1 to 695 1 to 695 Q93E S127R Y130H K136X S181X tiling clone,   695/695
(100 %)
4 diff
(99.5 %id)
BI016055 lung_tumor .i 1 to 175 177 to 2   tiling clone,   176/177
(99 %)
0 diff
(100 %id)
DB221473 trachea .i 154 to 698 2 to 546   tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
AK130992 pericardium .j 1 to 543 2 to 544 Q93E tiling clone, available from FLJ,   544/544
(100 %)
1 diff
(99.9 %id)
AW298312   .j 228 to 543 333 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 316/316
(100 %)
0 diff
(100 %id)
AW298314   .j 237 to 543 324 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 307/307
(100 %)
0 diff
(100 %id)
BM050549 eye, normal pigmented retinal epithelium .k 1 to 578 1 to 596 A4C F5L L6P I7H H8S ... tiling clone,   594/849
(69 %)
23 diff
(97.3 %id)
CN338336 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l-u 1 to 655 7 to 660 R39C E95K tiling clone,   654/660
(99 %)
4 diff
(99.4 %id)
BM930003 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m 1 to 446 1 to 446 exact tiling clone, AAA   446/446
(100 %)
0 diff
(100 %id)
BE718166 head_neck .n -9 to 488 511 to 14 R43T R44E R46P S47K G48R ... tiling clone,   498/511
(97 %)
2 diff
(99.7 %id)
BM709783 eye, Retina Foveal and Macular .n 28 to 231 1 to 204   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 204/204
(100 %)
1 diff
(99.6 %id)
BU733827 eye, Retina Foveal and Macular .n 170 to 807 649 to 12   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (42/42 A in genome downstream of last aligned base) 638/638
(100 %)
1 diff
(99.9 %id)
BF346264 anaplastic oligodendroglioma with 1p/19qloss, brain .n 326 to 990 1 to 663       663/671
(98 %)
4 diff
(99.5 %id)
BM800224 embryonal carcinoma, cell line, testis .n 328 to 1096 1 to 778   tiling clone,   778/1107
(70 %)
11 diff
(99.1 %id)
AA633373 breast .n 337 to 806 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AW615403 Kidney .n 380 to 616 237 to 1       237/237
(100 %)
0 diff
(100 %id)
DB510574 testis .n 470 to 810 1 to 341     Submitted on the opposite strand 341/341
(100 %)
0 diff
(100 %id)
AI123632 pooled .n 636 to 807 172 to 1       172/172
(100 %)
0 diff
(100 %id)
G42917   .n 642 to 791 1 to 150       150/150
(100 %)
0 diff
(100 %id)
BU191978 large cell carcinoma, lung .n 767 to 1577 1 to 824       824/979
(84 %)
28 diff
(97.2 %id)
BG680122 skin, squamous cell carcinoma .n 924 to 1748 1 to 842       842/879
(95 %)
16 diff
(98.2 %id)
BG029226 Bone, osteosarcoma, cell line .n 1004 to 1838 1 to 822   tiling clone,   822/902
(91 %)
23 diff
(97.5 %id)
BX091897 liver and spleen .n 1022 to 1762 1 to 742       742/742
(100 %)
5 diff
(99.4 %id)
BU185838 ductal carcinoma, cell line, Pancreas .n 1037 to 1882 1 to 851   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 851/851
(100 %)
17 diff
(98.1 %id)
AL706079 human skeletal muscle .n 1051 to 1675 1 to 627       627/627
(100 %)
5 diff
(99.3 %id)
CA413168 Chondrosarcoma Grade II, Left Pelvis .n 1129 to 1853 740 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 722/754
(95 %)
9 diff
(98.9 %id)
AA402077 ovarian tumor, ovary .n 1134 to 1476 1 to 342     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 342/342
(100 %)
4 diff
(98.9 %id)
BE830466 lung_tumor .n 1163 to 1435 1 to 273       273/283
(96 %)
4 diff
(98.6 %id)
BQ446673 Knee, Osteoarthritic Cartilage .n 1174 to 1853 696 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 678/678
(100 %)
2 diff
(99.8 %id)
CB055222 brain, glioblastoma (pooled) .n 1183 to 1853 695 to 25   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 671/671
(100 %)
0 diff
(100 %id)
BM827165 Ascites, stomach .n 1185 to 1603 1 to 419       419/419
(100 %)
0 diff
(100 %id)
BQ015904 lung, Metastatic Chondrosarcoma .n 1220 to 1844 643 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 625/625
(100 %)
2 diff
(99.7 %id)
AA303184 testis .n 1221 to 1532 1 to 312       312/312
(100 %)
0 diff
(100 %id)
AA349134 adrenal gland .n 1239 to 1551 1 to 314       314/316
(99 %)
7 diff
(97.8 %id)
BF792160 adrenal cortex carcinoma, cell line, adrenal gland .n 1261 to 1853 1 to 591       591/753
(78 %)
4 diff
(99.5 %id)
AW798410 uterus .n 1262 to 1507 1 to 247       247/252
(98 %)
6 diff
(97.7 %id)
BU631982 cell lines, Chondrosarcoma .n 1317 to 1853 555 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 537/538
(99 %)
2 diff
(99.7 %id)
AA948202 carcinoid, lung .n 1345 to 1723 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AA421036 ovarian tumor, ovary .n 1347 to 1839 1 to 493   fully sequenced,   493/493
(100 %)
0 diff
(100 %id)
AA479856 ovarian tumor, ovary .n 1347 to 1531 1 to 186   fully sequenced,   186/186
(100 %)
1 diff
(99.5 %id)
AA427360 ovarian tumor, ovary .n 1347 to 1525 1 to 179   fully sequenced,   179/179
(100 %)
1 diff
(99.5 %id)
AA442990 ovarian tumor, ovary .n 1347 to 1652 1 to 306   fully sequenced,   306/306
(100 %)
0 diff
(100 %id)
AW024190 Kidney .n 1389 to 1859 472 to 3       470/472
(99 %)
0 diff
(100 %id)
BF132403 hypernephroma, Kidney .n 1401 to 1858 1 to 458       458/822
(55 %)
5 diff
(99.4 %id)
AI609933 adenocarcinoma, Pancreas .n 1427 to 1850 426 to 3       424/426
(99 %)
0 diff
(100 %id)
AI357952 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 1459 to 1853 395 to 2       394/395
(99 %)
0 diff
(100 %id)
BE869711 adenocarcinoma, colon .n 1469 to 1858 1 to 388   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 388/388
(100 %)
2 diff
(99.5 %id)
AI244131 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .n 1491 to 1853 375 to 13   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 363/363
(100 %)
0 diff
(100 %id)
AA430338 ovarian tumor, ovary .n 1495 to 1858 363 to 1   fully sequenced,   363/363
(100 %)
1 diff
(99.8 %id)
AA479729 ovarian tumor, ovary .n 1501 to 1858 357 to 1   fully sequenced,   357/357
(100 %)
1 diff
(99.8 %id)
AA401913 ovarian tumor, ovary .n 1509 to 1858 366 to 18   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 349/349
(100 %)
2 diff
(99.5 %id)
AA303185 testis .n 1514 to 1856 344 to 1       344/344
(100 %)
16 diff
(95.4 %id)
AI242505 follicular lymphoma, lymph node .n 1514 to 1856 391 to 49   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 343/345
(99 %)
0 diff
(100 %id)
CD110714 Blood vessels - aorta, basilar and artery .n 1516 to 1819 1 to 304       304/307
(99 %)
2 diff
(99.4 %id)
AI521226 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 1537 to 1881 345 to 1   tiling clone,   345/345
(100 %)
4 diff
(98.9 %id)
AI741608 pooled .n 1548 to 1853 317 to 12   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 306/306
(100 %)
0 diff
(100 %id)
BU934307 mixed (pool of 40 RNAs) .n 1550 to 1859 1 to 310   tiling clone,   310/829
(37 %)
2 diff
(99.8 %id)
AA513767 breast .n 1580 to 1820 372 to 132   AAA   241/344
(70 %)
0 diff
(100 %id)
AA877065 metastatic prostate bone lesion .n 1601 to 1858 274 to 17   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 258/258
(100 %)
5 diff
(98.1 %id)
AA458479 ovarian tumor, ovary .n 1622 to 1858 237 to 1   fully sequenced,   237/237
(100 %)
0 diff
(100 %id)
BU533211 mixed (pool of 40 RNAs) .n 1624 to 1857 1 to 234   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 234/234
(100 %)
2 diff
(99.2 %id)
AA421037 ovarian tumor, ovary .n 1681 to 1858 177 to 1   fully sequenced,   177/177
(100 %)
0 diff
(100 %id)
BM993831 Bone, Subchondral Bone .n 1843 to 2517 693 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 675/675
(100 %)
3 diff
(99.6 %id)
CN479365 Bone, Subchondral Bone .n 1843 to 2517 693 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 675/675
(100 %)
3 diff
(99.6 %id)
BM762381 myeloma .n 1862 to 2467 1 to 608   tiling clone,   608/608
(100 %)
1 diff
(99.9 %id)
BM845253 myeloma .n 1862 to 1984 1 to 125   tiling clone,   125/125
(100 %)
1 diff
(99.2 %id)
AI885294 anaplastic oligodendroglioma, brain .n 2014 to 2515 503 to 1       503/503
(100 %)
0 diff
(100 %id)
AI889448 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n 2021 to 2515 496 to 1       496/496
(100 %)
2 diff
(99.6 %id)
AI538524 B-cell, chronic lymphotic leukemia .n 2055 to 2516 461 to 1       461/461
(100 %)
1 diff
(99.8 %id)
AI925632 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 2055 to 2523 469 to 1   tiling clone,   469/469
(100 %)
0 diff
(100 %id)
BE349517 malignant melanoma, metastatic to lymphnode, skin .n 2084 to 2521 438 to 1       438/438
(100 %)
2 diff
(99.6 %id)
AI092229 heart .n 2090 to 2523 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AI571812 anaplastic oligodendroglioma, brain .n 2139 to 2521 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
AI287614 placenta .n 2149 to 2525 377 to 1       377/377
(100 %)
7 diff
(98.2 %id)
BE327298 carcinoid, lung .n 2166 to 2522 358 to 2       357/358
(99 %)
0 diff
(100 %id)
AW016272   .n 2196 to 2509 338 to 25   AAA   314/320
(98 %)
0 diff
(100 %id)
AW016271   .n 2214 to 2515 320 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 302/302
(100 %)
4 diff
(98.7 %id)
BQ327206 colon_normal .n 2215 to 2511 66 to 362       297/363
(81 %)
9 diff
(97.6 %id)
CR739696 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n 2246 to 2515 284 to 15   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 270/281
(96 %)
1 diff
(99.7 %id)
AI271861 Kidney .n 2251 to 2530 280 to 1   tiling clone,   280/280
(100 %)
1 diff
(99.7 %id)
DA748227   .o 1 to 577 2 to 578   tiling clone, capped   577/577
(100 %)
9 diff
(98.5 %id)
DB325025   .o 1730 to 2249 520 to 1 exact tiling clone,   520/522
(99 %)
1 diff
(99.9 %id)
BC011985 Ovary, adenocarcinoma .p 1 to 1477 1 to 1477 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1477/1477
(100 %)
0 diff
(100 %id)
DA692692   .p 27 to 596 2 to 571 exact capped   570/570
(100 %)
0 diff
(100 %id)
DA841489 placenta .p 27 to 571 2 to 548 G35R V36G P37A H38P L39F ... capped   547/547
(100 %)
2 diff
(99.7 %id)
AA418513 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 1 to 529 3 to 530   tiling clone, fully sequenced,   528/530
(99 %)
10 diff
(98.2 %id)
BX108044 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 10 to 703 1 to 694 H14R T36A tiling clone,   694/694
(100 %)
4 diff
(99.5 %id)
AA418483 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 499 to 817 347 to 29   tiling clone, fully sequenced, AAA   319/319
(100 %)
3 diff
(99.1 %id)
CT004724 T-Lymphocytes .r 1 to 707 1 to 708 exact tiling clone,   708/713
(99 %)
6 diff
(99.2 %id)
BC042140 Blood, natural killer cell .r 20 to 724 1 to 705   tiling clone, available from MGC, AAA   705/705
(100 %)
3 diff
(99.6 %id)
BQ051453 blood, natural killer cells, cell line .r 22 to 719 1 to 699   available from MGC,   699/708
(98 %)
4 diff
(99.5 %id)
AA781313 parathyroid gland, parathyroid tumor .r 440 to 713 274 to 1       274/274
(100 %)
16 diff
(94.2 %id)
DA535549 heart .s-u 1 to 583 2 to 584   tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
DA455104 tongue, tumor tissue .s-u 33 to 623 2 to 592   tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
DB080820 testis .s-u 33 to 591 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP277385 Kidney .t 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
DA472664   .u 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
DA526176 brain .va 1 to 562 2 to 563 exact tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
AW859874 colon .vb-u 1 to 406 418 to 12 exact tiling clone,   407/427
(95 %)
0 diff
(100 %id)
BF895791 marrow .vb-u 168 to 539 30 to 399   tiling clone,   370/399
(92 %)
6 diff
(98.5 %id)
AW001563 colon, colonic mucosa from 3 patients with Crohn'sdisease .vc 1 to 534 534 to 1 G46E tiling clone,   534/534
(100 %)
2 diff
(99.7 %id)
CT002873 T-Lymphocytes .vc 110 to 536 1 to 427 G46E tiling clone, AAA   427/427
(100 %)
2 diff
(99.6 %id)
DA334316 hippocampus .vd 1 to 488 34 to 521 exact tiling clone, capped   488/488
(100 %)
2 diff
(99.6 %id)
DA314608 hippocampus .vd 4 to 534 2 to 533 A5C W6L W7V Q8A S9V ... capped   532/532
(100 %)
1 diff
(99.9 %id)
DA809011 brain .vd 4 to 535 2 to 533 exact tiling clone, capped   532/532
(100 %)
0 diff
(100 %id)
T08775   .vd 38 to 205 1 to 168       168/169
(99 %)
3 diff
(98.3 %id)
CB113116 Liver .vd 102 to 265 1 to 164       164/164
(100 %)
5 diff
(97.0 %id)
DA758457   .ve 1 to 531 2 to 532 exact tiling clone, capped   531/542
(97 %)
0 diff
(100 %id)
DB183145 liver, tumor tissue .vf 1 to 507 2 to 508 exact tiling clone, capped   507/507
(100 %)
0 diff
(100 %id)
BF892040 marrow .vg-u 1 to 315 12 to 326 C5A Q6R A7H M8G V10A ... tiling clone,   315/335
(94 %)
6 diff
(98.3 %id)
BX481311   Gene C20orf29andMAVS, variant not shown         Submitted on the opposite strand    
282 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q, .r, .s-u, .t, .u, .va, .vb-u, .vc, .vd, .ve, .vf, .vg-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI